Extreme aging is adaptation, not simply decline
In the vast human search for the secrets of a long and vital life, scientists at the University of São Paulo have turned their attention not to the familiar longevity villages of Japan or Sardinia, but to Brazil — a nation whose centuries of migration, slavery, and indigenous heritage have woven a genetic tapestry unlike any other on Earth. Studying more than 160 centenarians and 20 validated supercentenarians, researchers have found that extreme old age here is not merely a matter of survival, but of biological adaptation: rare genetic variants, resilient immune systems, and cellular machinery that continues to cleanse and protect long past the point where most bodies surrender. The discovery invites a deeper question — how much of what we thought we knew about aging was shaped by the populations we chose, and failed, to study.
- Brazil has quietly produced an unusual number of people who live past 110 with their minds and bodies largely intact, a phenomenon that mainstream longevity science has largely overlooked.
- The tension lies in a field dominated by European and Asian cohorts: millions of protective genetic variants unique to Brazil's mixed-ancestry populations have gone undocumented and unstudied until now.
- Three Brazilian supercentenarians survived COVID-19 in 2020 before vaccines existed, mounting immune responses that stunned researchers and pointed to biological defenses operating well beyond normal human limits.
- Family clusters — including one with a woman nearing 110 whose nieces are 100, 104, and 106 — suggest that whatever is happening is heritable, concentrated, and potentially mappable.
- Brazilian scientists are now pressing for international research to expand beyond homogeneous populations, positioning their country as a future global hub for precision medicine and healthy aging.
Scientists at the University of São Paulo are mapping the biology of extreme old age in Brazil — a country rarely named alongside the world's famous longevity hotspots — and what they are finding may rewrite assumptions that have guided decades of research.
Led by geneticist Mayana Zatz and published in Genomic Psychiatry, the study examines more than 160 centenarians and 20 validated supercentenarians, including Sister Inah Canabarro Lucas, recognized as the world's oldest person before her death in April 2025 at 116. Many of these individuals retained mental sharpness and physical independence at ages that defy conventional understanding of human decline.
The explanation, researchers argue, lies in genetics — specifically the extraordinary diversity produced by centuries of European immigration, African slavery, and indigenous mixing. When the team analyzed over a thousand Brazilians above 60, they uncovered millions of previously undocumented genetic variants, many tied to immune function and cellular aging. Lead author Mateus Vidigal de Castro notes that mestizo supercentenarians may carry protective variants entirely invisible in the more uniform populations that have long dominated longevity science.
The biological picture is striking: these individuals maintain cellular mechanisms that eliminate damaged proteins, and display unusual immune patterns — including expanded CD4+ T cells capable of destroying infected cells. The COVID-19 pandemic offered unexpected confirmation of this resilience, when three supercentenarians survived the virus in 2020 before vaccines existed, generating exceptional antibody responses. Family clusters reinforce the hereditary dimension, with siblings of centenarians found to be five to seventeen times more likely to reach extreme ages themselves.
The broader implication is a challenge to the field itself. By concentrating on genetically homogeneous populations, longevity research may have systematically missed the protective variants hidden within the world's most diverse communities. Brazil's scientists are now calling for international studies to correct that blind spot — and in doing so, to transform their country into a global center for understanding what it truly means to age well.
Scientists at the University of São Paulo have begun mapping the biological architecture of extreme old age, and what they're finding suggests that Brazil—a country rarely mentioned alongside the world's famous longevity hotspots—may hold secrets that decades of research in Japan and Europe have missed.
The study, led by geneticist Mayana Zatz and published in Genomic Psychiatry, focuses on a striking phenomenon: Brazil has produced an unusual number of supercentenarians—people who have lived past 110 years—and many of them have done so while retaining mental sharpness, physical independence, and a biological resilience that defies the typical wear of extreme age. The research team at the Center for Human Genome and Stem Cell Research has been examining more than 160 centenarians and 20 validated supercentenarians from across the country, including Sister Inah Canabarro Lucas, who was recognized as the world's oldest person until her death in April 2025 at 116 years old.
What makes Brazil's longevity story different is not climate or diet or a single cultural practice, but genetics—specifically, the genetic diversity that emerged from centuries of European immigration, African slavery, and indigenous populations mixing together. This has created a genetic landscape unlike anywhere else on Earth. When researchers analyzed more than a thousand Brazilians over 60, they identified millions of genetic variants that had never been documented before, many of them connected to immune function and the cellular machinery that controls aging. As Mateus Vidigal de Castro, the study's lead author, explains, this diversity matters enormously for longevity research: mestizo supercentenarians may carry protective genetic variants that remain completely invisible in the more genetically uniform populations that have dominated scientific study.
The biological differences the team discovered in these extreme-age individuals are striking. Supercentenarians maintain active cellular mechanisms that can eliminate damaged proteins and mount better defenses against disease. They show unusual immune patterns, including an expansion of CD4+ T cells with cytotoxic functions—cells that can destroy infected cells in ways similar to other immune defenders. The genetic analysis revealed rare variants linked to immunity, genetic stability, and cellular protection. What this suggests is that extreme aging in these individuals is not simply a story of decline, but rather a form of biological adaptation that allows essential functions to persist far longer than normal.
The COVID-19 pandemic provided an unexpected window into this resilience. Three Brazilian supercentenarians contracted the virus in 2020, before vaccines arrived, and survived it—developing high levels of neutralizing antibodies and immune responses considered exceptional for people their age. The researchers interpret these cases as evidence of extraordinary biological survival mechanisms. There are also striking family clusters: one Brazilian family includes a woman approaching 110 with nieces aged 100, 104, and 106, one of whom was a competitive swimmer at 100. Previous research has shown that siblings of centenarians are five to seventeen times more likely to reach extreme ages themselves.
The implications extend beyond Brazil's borders. Most genetic research on longevity has concentrated on relatively homogeneous European and Asian populations, potentially missing protective variants present in more genetically diverse communities. Brazilian researchers are now pushing for international studies to expand beyond these traditional cohorts and include mestizo and genetically diverse populations. If successful, Brazil could become a global research hub for understanding healthy aging and precision medicine—filling a critical gap in a field that has long overlooked the genetic wealth of mixed-ancestry populations.
Citações Notáveis
Mestizo supercentenarians may carry protective genetic variants that remain invisible in more genetically uniform populations— Mateus Vidigal de Castro, lead author of the study
A Conversa do Hearth Outra perspectiva sobre a história
Why does Brazil's genetic diversity matter so much for longevity research? Couldn't you study aging anywhere?
Because most of the genetic variants that protect against aging in mixed-ancestry populations have never been catalogued. They're invisible in homogeneous populations. You're missing half the story if you only look at Europe and Asia.
But Brazil isn't known as a place where people live exceptionally long lives. Why is it producing so many supercentenarians?
That's the puzzle. It's not about the climate or the food or some cultural secret. It's that the genetic mixing created combinations of protective variants that exist nowhere else. The science is still catching up to what's actually happening.
What did you learn from the three supercentenarians who survived COVID before vaccines existed?
That their immune systems work differently. They generated antibody responses that shouldn't be possible at that age. It suggests their bodies have mechanisms to fight infection that most people lose long before 110.
Is this hereditary? Can you predict who will live to 110?
There's a strong family component. If your sibling reaches 100, you're five to seventeen times more likely to as well. But it's not destiny—it's a combination of genetics and how those genes are expressed over a lifetime.
What happens next with this research?
They need to expand the studies internationally, include more genetically diverse populations. Right now, longevity research is built on a narrow genetic foundation. Brazil could change that.